Indoco Remedies (BOM:532612) ROCE % : 3.27% (As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Indoco Remedies's annualized ROCE % for the quarter that ended in Sep. 2024 was 3.27%.

Indoco Remedies ROCE % Historical Data

The historical data trend for Indoco Remedies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies ROCE % Chart

Indoco Remedies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

6.26

17.79

25.70

18.87

12.50

Indoco Remedies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															15.88	9.55	11.51	5.55	3.27

Indoco Remedies ROCE % Calculation

Indoco Remedies's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	1728.777	/	( ( (16581.984 - 4245.07)	+	(21447.285 - 6123.286) )	/ 2 )
	=	1728.777	/	( (12336.914	+	15323.999)	/ 2 )
	=	1728.777	/	13830.4565
	=	12.50 %

Indoco Remedies's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	519.6	/	( ( (0 - 0)	+	(23898.3 - 8007.9) )	/ 1 )
	=	519.6	/	( ( 0	+	15890.4 )	/ 1 )
	=	519.6	/	15890.4
	=	3.27 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Indoco Remedies (BOM:532612) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Indoco Remedies ROCE % Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Indoco Remedies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » ROCE %

Traded in Other Exchanges

INDOCO:India

Address

166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098

Website

https://www.indoco.com

Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines